AbbVie shares fell after six-session winning streak
Seeking Alpha ·
AbbVie ( ABBV ) shares snapped six straight sessions of gains on Tuesday, as the stock was 1.3% lower at $251.13. The biopharmaceutical company gained 10.6% in the preceding six sessions. ABBV climbed over 6% alone after the company agreed to acquire
DYAX Investor Sentiment
Bullish (Long) 43% · Bearish (Short) 57%
283 participants
Related News
- Oceaneering prices tender offer for 2028 Senior Notes
- Osprey Acquisition Corp. III announces pricing of $261M initial public offering
- Firefly wins $144M NASA lunar delivery contract
- Why The Trade Desk Stock Tumbled on Tuesday
- Strategy Just Announced a Major Revamp to Its Bitcoin Strategy. Here's What Investors Should Know
- Financial sector climbs in Q2 as Robinhood leads gainers, CME heads losers